The role of microbiome-containing moisturizers in atopic dermatitis
Keywords:
atopic dermatitis, dsybiosis, microbiome, microbiota, moisturizerAbstract
Atopic dermatitis (AD) is a chronic inflammatory and very itchy skin condition. One theory for AD development is microbiota dysbiosis on the skin's surface. Based on this hypothesis, microbiome-containing moisturizers have been investigated as an alternative treatment for AD. This study seeks to provide the most recent information on using moisturizers with microbiomes in AD.References
Kapur S, Watson W, Carr S. Atopic dermatitis. Allergy Asthma Clin Immunol. 2018;14(2):43-52.
Nakatsuji T, Gallo RL. The role of the skin microbiome in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(3):263-9.
Guo Y, Dou X, Jian XL, Zhang KY, Zheng YJ, Yu B. Effect of treatments on skin microbiota in patients with atopic dermatitis: A protocol for systematic review. BMJ Open. 2022;12(1):e053488.
Salava A, Lauerma A. Role of the skin microbiome in atopic dermatitis. Clin Transl Allergy. 2014;4:33.
Effendi R, Dwiyana R. Skin Microbiota and its role in atopic dermatitis. Media Dermato-Venereologica Indonesiana. 2022; 49(1):50–6.
Paramita DA, Khairina, Lubis NZ. Bacterial colonization in atopic dermatitis. Bali Med J. 2022;11(3):1924–9.
Paller AS, Mancini AJ, editors. Eczematous Eruptions in Childhood. In: Hurwitz Clinical Pediatric Dermatology. 6th ed. Missouri: Elsevier; 2022. p. 42–61.
Pothmann A, Illing T, Wiegand C, Hartmann AA, Elsner P. The Microbiome and Atopic Dermatitis: A Review. Am J Clin Dermatol. 2019;20:749-61.
Ramadan M, Solyman S, Yones M, Abdallah Y, Halaby H, Hanora A. Skin microbiome differences in atopic dermatitis and healthy controls in Egyptian children and adults, and association with serum immunoglobulin E. OMICS. 2019; 23(5):247–60.
Flohr C, Silverberg JI, Wan J, Langan SM. Epidemiology of Atopic Dermatitis. In: Hoeger P, et al., editors. Harper’s Textbook of Pediatric Dermatology. 4th ed. New Jersey: Wiley Blackwell; 2020. p. 167–83.
Solman L, Glover M. Management of Atopic Dermatitis. In: Hoeger P, Kinsler V, Yan A, editors. Harper’s Textbook of Pediatric Dermatology. 4th ed. New Jersey: WIley Blackwell; 2020. p. 253–64.
Popadić S, Gajić-Veljić M, Prćić S, Mijušković Ž, Jovanović D, Kandolf-Sekulović L, et al. National Guidelines for the Treatment of Atopic Dermatitis. Serbian J Dermatol Venereol. 2016;8(3):129–53.
Dou J, Zeng J, Wu K, Tan W, Gao L, Lu J. Microbiosis in pathogenesis and intervention of atopic dermatitis. Int Immunopharmacol. 2019;69:263-9.
Dietert RR, Dietert JM. The microbiome and sustainable healthcare. Healthcare. 2015; 3(1):100–29.
Sudarmono PP. The Microbiome: New understanding of the role of microorganisms in human life. eJournal Kedokteran Indonesia. 2016;4(2):71–5.
Williams MR, Gallo RL. The Role of the Skin Microbiome in Atopic Dermatitis. Curr Allergy Asthma Rep. 2015;15(65):1–10.
Schommer NN, Gallo RL. Structure and function of the human skin microbiome. Trends Microbiol. 2013;21(12):660–8.
Luna PC. Skin Microbiome as years go by. Am J Clin Dermatol. 2020;21(1):12–7.
Wollina U. Microbiome in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:51-6.
Lee SY, Lee E, Park YM, Hong SJ. Microbiome in the Gut-Skin Axis in atopic Dermatitis. Allergy Asthma Immunol Res. 2018;10(4):354-62.
Umborowati MA, Salsabila Nurdini Wilda, Damayanti, Anggraeni S, Prakoeswa CRS. The role of skin and gut microbiome in atopic dermatitis. J Pak Assoc Dermatol. 2022;32(1):48–55.
Powers CE, McShane DB, Gilligan PH, Burkhart CN, Morrell DS. Microbiome and pediatric atopic dermatitis. J Dermatol. 2015;42(12):1137-42.
Koh LF, Ong RY, Common JE. Skin microbiome of atopic dermatitis. Allergol Int. 2022;71(1):31-9.
Ananda S, John E, Tamami MF, Hidajat D. Skin Microbiome and the role of probiotics in atopic dermatitis. Jurnal Kedokteran Unram. 2022;11(1):739–46.
Seité S, Zelenkova H, Martin R. Clinical efficacy of emollients in atopic dermatitis patients - relationship with the skin microbiota modification. Clin Cosmet Investig Dermatol. 2017;10:25–33.
Christensen IB, Vedel C, Clausen ML, Kjærulff S, Agner T, Nielsen DS. Targeted screening of lactic acid bacteria with antibacterial activity toward staphylococcus aureus clonal complex type 1 associated with atopic dermatitis. Front Microbiol. 2021;12:733847.
Crespo C. Bacterial derivatives of lactococcus lactis and ectoin for atopic dermatitis: Dermal compatibility and cosmetic acceptability. Pharm Pharmacol Int J. 2017;5(6):226-31.
Di Marzio L, Centi C, Cinque B, Masci S, Giuliani M, Arcieri A, et al. Effect of the lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp Dermatol. 2003;12:615-20.
Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: A prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol. 2008;159(6):1357–63.
Park SB, Im M, Lee Y, Lee JH, Lim J, Park YH, et al. Effect of emollients containing vegetable-derived lactobacillus in the treatment of atopic dermatitis symptoms: Split-body clinical trial. Ann Dermatol. 2014;26(2):150–5.
Blanchet-Réthoré S, Bourdès V, Mercenier A, Haddar CH, Verhoeven PO, Andres P. Effect of a lotion containing the heat-treated probiotic strain Lactobacillus johnsonii NCC 533 on Staphylococcus aureus colonization in atopic dermatitis. Clin Cosmet Investig Dermatol. 2017;10:249-57.
Myles IA, Earland NJ, Anderson ED, Moore IN, Kieh MD, Williams KW, et al. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight. 2018;3(9):e120608.
Butler É, Lundqvist C, Axelsson J. Lactobacillus reuteri DSM 17938 as a novel topical cosmetic ingredient: A proof of concept clinical study in adults with atopic dermatitis. Microorganisms. 2020;8(7):1-15.
Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, et al. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase I randomized clinical trial. Nat Med. 2021;27(4):700–9.
